Plasma insulin and C-peptide concentrations in diabetic patients undergoing hemodialysis: Comparison with 5 types of high-flux dialyzer membranes

Plasma insulin and C-peptide concentrations in diabetic patients undergoing hemodialysis: Comparison with 5 types of high-flux dialyzer membranes - IRI and CPR removal by dialyzers

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002645

Enrollment

Registered

2009-10-21

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients with diabetes

Interventions

Using PS membrane Using PES membrane Using CTA membrane Using PMMA membrane Using PEPA membrane

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stable hemodialysis patients who are treated three times/week for 4 hours.

Exclusion criteria

Exclusion criteria: 1)Patients with unstable glycemic control.2)Patients with severe infectious disease, malignancy, and who were being treated with steroids. 3) Patients who are not able to change the dialyzer due to allergy.

Design outcomes

Primary

Measure	Time frame
Evaluation of the changes in the plasma IRI and CPR concentrations resulting from using 5 types of dialyzer membranes.	—

Countries

Japan

Contacts

Public ContactMasanori Abe

Nihon University School of Medicine Nephrology, Hypertenson, and Endoclinology

mabe@med.nihon-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026